Development and Validation of a Targeted ‘Liquid’ NGS Panel for Treatment Customization in Patients with Metastatic Colorectal Cancer

The detection of actionable mutations in tumor tissue is a prerequisite for treatment customization in patients with metastatic colorectal cancer (mCRC). Analysis of circulating tumor DNA (ctDNA) for the identification of such mutations in patients’ plasma is an attractive alternative to invasive ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kastrisiou, Myrto, Zarkavelis, George, Kougioumtzi, Anastasia, Sakaloglou, Prodromos, Kostoulas, Charilaos, Georgiou, Ioannis, Batistatou, Anna, Pentheroudakis, George, Magklara, Angeliki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700616/
https://www.ncbi.nlm.nih.gov/pubmed/34943612
http://dx.doi.org/10.3390/diagnostics11122375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700616/
https://www.ncbi.nlm.nih.gov/pubmed/34943612
http://dx.doi.org/10.3390/diagnostics11122375

Ejemplares similares